Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
Price Target
Average
94.18%
Revenue Forecast
Estimate
1.51%
EBIT
Estimate
17.46%
Net Income
Estimate
38.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biogen Inc.
Wall Street analysts predict an average 1-year price target for BIIB of $273 , with forecasts ranging from
a
low of
$180 to a high of $342 .
BIIB Lowest Price Target
Wall Street Target
180 USD
28.07%
BIIB Average Price Target
Wall Street Target
273 USD
94.18%
BIIB Highest Price Target
Wall Street Target
342 USD
143.33%
REVENUE FORECAST
Revenue Forecast Chart BIIB
EBIT FORECAST
EBIT Forecast Chart BIIB
NET INCOME FORECAST
Net Income Chart BIIB